Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

The $200 Popcorn Popper That Keeps Selling Out

October 1, 2026

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Active Implantable Medical Devices (AIMD) Forecasts Report 2025: Market to Reach $49.19 Billion by 2030, Driven by Strong Demand for Pacemakers and Neurostimulators, & Chronic Illness Management
Press Release

Active Implantable Medical Devices (AIMD) Forecasts Report 2025: Market to Reach $49.19 Billion by 2030, Driven by Strong Demand for Pacemakers and Neurostimulators, & Chronic Illness Management

By News RoomOctober 10, 20255 Mins Read
Active Implantable Medical Devices (AIMD) Forecasts Report 2025: Market to Reach .19 Billion by 2030, Driven by Strong Demand for Pacemakers and Neurostimulators, & Chronic Illness Management
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Oct. 10, 2025 (GLOBE NEWSWIRE) — The “Active Implantable Medical Devices (AIMD) Market – Forecasts from 2025 to 2030” report has been added to ResearchAndMarkets.com’s offering.

The Active Implantable Medical Devices (AIMD) Market is expected to grow from USD 35.195 billion in 2025 to USD 49.197 billion in 2030, at a CAGR of 6.93%.

The global active implantable medical devices (AIMD) market is experiencing significant growth, driven by technological advancements, an aging population, and the rising prevalence of chronic diseases. AIMDs, such as pacemakers and neurostimulators, are critical for monitoring and treating conditions, particularly in geriatric patients.

The AIMD market is poised for robust growth through 2025, driven by the rising burden of chronic diseases, technological advancements, and supportive policies. The U.S. leads due to its aging population and high disease prevalence, while Asia-Pacific shows strong potential. Challenges such as high costs and regulatory complexities must be addressed to sustain growth. Industry players are expected to focus on AI integration and innovative product launches to meet evolving healthcare demands.

Market Drivers

  • Rising Prevalence of Chronic Diseases in the Aging Population: The growing incidence of chronic conditions, such as cardiovascular diseases, diabetes, and neurological disorders, among older adults is a primary driver of the AIMD market. These devices play a vital role in managing complex healthcare needs, improving patient outcomes, and enhancing quality of life. The increasing elderly population globally amplifies demand for AIMDs, as healthcare providers seek advanced solutions to address age-related health challenges.
  • Technological Advancements and AI Integration: Innovations in AIMD technology, including the integration of artificial intelligence (AI) for patient-specific diagnostics, are propelling market growth. AI-enabled devices enhance monitoring precision and treatment efficacy, driving adoption. Ongoing research and development, along with expanded indications for existing AIMDs, further fuel innovation, positioning the market for sustained growth.
  • Supportive Government Policies and Funding: Regulatory frameworks, such as the Republic of Korea’s Act on Fostering the Medical Devices Industry and Supporting Innovative Medical Devices, are fostering AIMD development. Government funding and increased awareness of AIMD benefits are encouraging investment in research and product launches, supporting market expansion.

Market Restraints

  • High Costs and Regulatory Challenges: The high cost of developing and manufacturing AIMDs, coupled with stringent regulatory requirements, poses challenges to market growth. Compliance with diverse global standards increases production costs and timelines, potentially limiting accessibility in cost-sensitive markets.
  • Limited Awareness in Emerging Markets: Despite growing demand, limited awareness of AIMD benefits in certain regions, particularly in developing economies, may hinder market penetration. Educating healthcare providers and patients about the advantages of AIMDs remains a critical challenge.

Geographical Outlook

  • North America (United States): The U.S. is expected to hold the largest market share, driven by the high prevalence of cardiovascular diseases. The aging population, representing 17% of the U.S. population in 2022 per World Bank data, further boosts demand for AIMDs. Technological advancements, such as Abbott Laboratories FDA-approved AVEIR dual-chamber pacemaker in July 2023, enhance market growth by offering innovative solutions for heart rhythm disorders.
  • Asia-Pacific: Countries like India, with a high burden of chronic diseases (21% of the elderly affected, per the National Library of Medicine), are seeing increased demand for AIMDs. Supportive regulatory frameworks and investments in healthcare infrastructure are driving growth in this region.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries

Key Attributes:

Report Attribute Details
No. of Pages 146
Forecast Period 2025 – 2030
Estimated Market Value (USD) in 2025 $35.2 billion
Forecasted Market Value (USD) by 2030 $49.2 billion
Compound Annual Growth Rate 6.9%
Regions Covered Global


Company Profiling: Strategies, Products, Financial Information, and Key Developments

  • Sonova Holding AG
  • Medtronic
  • Abbott
  • Lifetech Scientific
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • MED-EL
  • Biotronik SE & Co. KG
  • LivaNova PLC

Active Implantable Medical Devices (AIMD) Market Segmentation:

By Product

  • Ventricular Assist Devices
  • Neurostimulators
  • Implantable Cardiac Pacemakers
  • Cochlear Implants
  • Others

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Home Care Settings

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia Pacific

For more information about this report visit https://www.researchandmarkets.com/r/zey4a2

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Active Implantable Medical Devices (AIMD) Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

The $200 Popcorn Popper That Keeps Selling Out

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya

The News Forum Presents Aftershock: The World After October 7, 2023

BloFin returns as TOKEN2049 Singapore title sponsor, opens its “NEXT WHALE ERA” chapter with 3rd anniversary afterparty

Editors Picks

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026

Latest News

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

October 1, 2026

Police seek answers in crash that killed 2 elders, hurt 2 others on BC First Nation

October 1, 2026

An AI agent tried to hack Canadian government website, researchers say

October 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version